Xiawei WEI
7Patents
1h-index
25Co-inventors
43Inventor score
Filing activity: Oct 14, 2016 → Mar 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11738072B2 | Tumor vaccine and uses thereof | Human Necessities | 1 | Active |
| US11739090B2 | Substituted pyrazlo[3,4-c]pyridines as selective BTK kinase inhibitors | Human Necessities | 0 | Active |
| US11136315B2 | CXCR2 antagonist | Chemistry; Metallurgy | 0 | Active |
| US11839657B2 | Ionizable lipids and compositions for nucleic acid delivery | Chemistry; Metallurgy | 0 | Active |
| US12310948B2 | Application of monocyclic β-lactam compound in pharmacy | Chemistry; Metallurgy | 0 | Active |
| US10869922B2 | Alhydrogel-sodium chloride compound immunologic adjuvant, preparation method and use thereof | Human Necessities | 0 | Active |
| US11046720B2 | Dimethylphosphine oxide compound | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.